anti-PD-L1 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-PD-L1 inhibitor, covering 2025-10-28 to 2025-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) [Phase 2]